Number of the records: 1  

Serum and urinary levels of CD222 in cancer: origin and diagnostic value

  1. TitleSerum and urinary levels of CD222 in cancer: origin and diagnostic value
    Author Vičíková Kristína SAVMOBIO - Ústav molekulárnej biológie SAV
    Co-authors Petrovčíková Eva SAVMOBIO - Ústav molekulárnej biológie SAV

    Manka P.

    Drach J.

    Stockinger H.

    Leksa Vladimír SAVMOBIO - Ústav molekulárnej biológie SAV

    Source document Neoplasma. Vol. 65 (2018), p. 762-768
    Languageeng - English
    Document kindrozpis článkov z periodík (rbx)
    CitationsLIU, S.B. - ZHOU, L.B. - WANG, H.F. - LI, G. - XIE, Q.P. - HU, B. Loss of IGF2R indicates a poor prognosis and promotes cell proliferation and tumorigenesis in bladder cancer via AKT signaling pathway. In NEOPLASMA. ISSN 0028-2685, 2020, vol. 67, no. 1, p. 129-136.
    MUGHEES, M. - KUMAR, K. - WAJID, S. Exosome vesicle as a nano-therapeutic carrier for breast cancer. In JOURNAL OF DRUG TARGETING. ISSN 1061-186X, FEB 7 2021, vol. 29, no. 2, p. 121-130.
    KHAN, Safir Ullah - KHAN, Munir Ullah - GAO, Yanyan - KHAN, Muhammad Imran - PUSWAL, Sabah Mushtaq - ZUBAIR, Muhammad - KHAN, Muhammad Ammar - FARWA, Rahat - GAO, Shuang - ALI, Rizwan - HUSSAIN, Nazim. Unique therapeutic potentialities of exosomes based nanodrug carriers to target tumor microenvironment in cancer therapy. In OpenNano, 2022-11-01, 8, pp. ISSN 23529520. Dostupné na: https://doi.org/10.1016/j.onano.2022.100091.
    CategoryADDA - Scientific papers in domestic journals registered in Current Contents Connect with IF (impacted)
    Category of document (from 2022)V3 - Vedecký výstup publikačnej činnosti z časopisu
    Type of documentčlánok
    Year2018
    Registered inWOS
    Registered inSCOPUS
    Registered inCCC
    DOI 10.4149/neo_2018_171203N792
    article

    article

    File nameAccessSizeDownloadedTypeLicense
    Serum and urinary levels of CD222 in cancer origin and diagnostic value.pdfavailable813.8 KB0Publisher's version
    rokCCIFIF Q (best)JCR Av Jour IF PercSJRSJR Q (best)CiteScore
    A
    rok vydaniarok metrikyIFIF Q (best)SJRSJR Q (best)
    201820171.696Q40.639Q3
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.